Literature DB >> 2176355

[The superior vena cava syndrome as an emergency in radiotherapy].

C Beck1, W Berberich, A Bauknecht, K Schnabel.   

Abstract

Between 1983 and 1988 90 patients with bronchial neoplasms needed emergency irradiation to treat superior vena cava syndrome. Pathohistologically verified were 30 cases with squamous cell carcinoma, twelve with adenocarcinoma, five cases with large cell carcinoma, 30 with a small cell carcinoma, and non-differentiated in five others. No histological examination was carried out in eight cases. Im 30 patients distant metastases were evident at the initial diagnosis. The average duration of follow-up was 118 days. The survival course proved to be independent of histopathological grading, previous treatment, and age. Similarly no influence of the fractionation employed could be seen. Very important to the prognosis however, were the stage of disease, the Karnofsky index, and dependent on that, the total reference dose applied. Patients with a Karnofsky index of 50% or lower survived on average only 17 days.

Entities:  

Mesh:

Year:  1990        PMID: 2176355

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  4 in total

1.  [Facial edemas in a 61-year old patient].

Authors:  S Kappes; M Kunz; G Klautke; H Terpe; G Gross
Journal:  Hautarzt       Date:  2002-09       Impact factor: 0.751

2.  Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.

Authors:  K W Stock; A L Jacob; M Proske; C T Bolliger; C Rochlitz; W Steinbrich
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

3.  Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years' practice.

Authors:  Manuel Guhlich; Teresa Esther Maag; Leif Hendrik Dröge; Rami A El Shafie; Andrea Hille; Sandra Donath; Markus Anton Schirmer; Olga Knaus; Friedemann Nauck; Tobias Raphael Overbeck; Marc Hinterthaner; Wolfgang Körber; Stefan Andreas; Achim Rittmeyer; Martin Leu; Stefan Rieken
Journal:  Strahlenther Onkol       Date:  2022-05-12       Impact factor: 3.621

4.  Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches.

Authors:  Ting Mei; Weigang Xiu; Xuexi Yang; Xiaoman Tian; Yang Yu; Yong Xu; Lin Zhou; Xiaojuan Zhou; Yongmei Liu; Bingwen Zou; Jianxin Xue; Rui Ao; You Lu; Youling Gong
Journal:  Strahlenther Onkol       Date:  2021-04-28       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.